Symrise reports USD 3B revenue with 3.1% organic growth in H1 FY25

This performance highlights strong segment performance, margin gains, and continued progress on its transformation strategy.

GERMANY – Symrise AG has announced solid financial and operational results for the first half of 2025, demonstrating resilience amid a challenging global economic environment. 

The company delivered organic sales growth of 3.1%, achieving reported revenues of €2,554 million(USD 2.92 million), driven by strong demand in key markets and a robust pipeline of customer projects.

Gross profit rose by 6.0% year-on-year to €1,057 million(USD 1.21 billion), with the gross margin climbing 250 basis points to 41.4%, supported by a shift toward value-added sales.

EBITDA rose 4.5% year-on-year to €554 million(USD 631.56 million), with the EBITDA margin improving by 100 basis points to 21.7%, driven by profitable sales and efficiency efforts.

Symrise reported steady performance in H1 2025, with the Taste, Nutrition & Health segment achieving 3.3% organic growth and €364 million(USD 415 million) in EBITDA, up 4.7%. 

The Scent & Care segment grew organically by 2.9%, with EBITDA rising to €190 million(USD 220.19 million).

Both segments saw margin improvements driven by efficiency gains and strong category performance.

The company progressed with its ONE SYM Transformation, identifying €40 million(USD 47.2 million) in additional cost savings and streamlining its portfolio through planned divestitures.

Business Free Cash Flow remained stable at €226 million(USD 261.16 million).

Net debt rose to €2.046 billion(USD 2.33 billion), remaining within the target leverage range. Net income improved to €268 million(USD 311.18 million), with earnings per share increasing 12% to €1.92(USD 2.20).

Jean-Yves Parisot, CEO of Symrise AG, stated, “We have embarked on this journey to take the best of Symrise and transform into a company that generates durable profitable growth, strong business free cash flow, and compounding returns.”

Amid an increasingly challenging consumer backdrop, our efforts will result in a structurally stronger Symrise and position us well to capture market share and deliver operating leverage as demand strengthens.”

Symrise has adjusted its full-year 2025 guidance in response to softer global demand and ongoing transformation efforts. 

The company now expects organic sales growth of 3%–5%, down from the previous 5%–7% range. 

However, it has raised its EBITDA margin outlook to around 21.5%, up from ~21%, and maintains its Business Free Cash Flow target at ~14% of sales.

Additionally, Symrise has introduced €40 million(USD$47.1 million) in annual cost savings and reaffirmed its 2028 mid-term goals, targeting 5%–7% organic CAGR growth and 21%–23% EBITDA margin.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.

Newer Post

Thumbnail for Symrise reports USD 3B revenue with 3.1% organic growth in H1 FY25

MyMicrobiome unveils new standard for Eczema-Prone Skin

Older Post

Thumbnail for Symrise reports USD 3B revenue with 3.1% organic growth in H1 FY25

Fragrance category booms as consumers shift to affordable indulgences, report finds